Research & Papers

Sampled-data Robust Control of Electrically Stimulated Engineered Cell Factories

Closed-loop adaptive PID handles delays, noise, and burst actuation in engineered cells.

Deep Dive

Researchers from the team of Papri Dey, Ksenia Zoblina, Nicholas A. Rondoni, and Marcella M. Gomez have introduced a new control framework for closed-loop bioelectronic regulation of engineered secretory cell systems. Their work, published on arXiv under title "Sampled-data Robust Control of Electrically Stimulated Engineered Cell Factories," addresses the inherent challenges of electric-field (EF) stimulation—indirect activation through transcription factors, delayed and nonlinear intracellular dynamics, sparse measurements, and constrained burst-based actuation. The plant model is built using a control-oriented ordinary differential equation (ODE) that integrates a reduced mechanistic pathway for extracellular thyroid hormone T4 production, an EF-responsive Hill module, and a linear-chain Erlang cascade to represent distributed intracellular delays. On this basis, the team designed a sampled-data adaptive proportional-integral-derivative (APID) controller enhanced with derivative filtering, anti-windup, saturation and rate limits, and hysteretic band-locking.

To achieve robustness, the authors extended the controller to a robust adaptive PID (RAPID) that explicitly accounts for parameter mismatch, sensor noise and bias, actuator mismatch, delay/jitter, and exogenous rhythmic disturbances via a scenario-based risk-aware update. They provide local sampled-data input-to-state stability interpretations for both APID and RAPID, proving that under standard Lyapunov and bounded-disturbance conditions, the sampled tracking error remains ultimately bounded by a disturbance-dependent constant. In silico experiments focus on sustained regulation of extracellular T4 in engineered thyroid-like cells, demonstrating the controller's ability to maintain prescribed targets despite significant uncertainty. This work represents a significant step toward reliable closed-loop bioelectronic control of engineered cell factories, with potential applications in therapeutic hormone production and cellular manufacturing.

Key Points
  • RAPID controller combines adaptive PID with derivative filtering, anti-windup, saturation, rate limits, and hysteretic band-locking for constrained burst actuation.
  • Robust extension handles parameter mismatch, sensor noise, actuator mismatch, delay/jitter, and exogenous rhythmic disturbances via risk-aware updates.
  • In silico validation on engineered thyroid-like cells shows sustained T4 regulation across prescribed targets despite significant uncertainty.

Why It Matters

Enables reliable closed-loop bioelectronic control of engineered cell factories for therapeutic hormone production and cellular manufacturing.